Insider Transactions in Q2 2021 at Global Blood Therapeutics, Inc. (GBT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2021
|
Philip A. Pizzo Director |
SELL
Open market or private sale
|
Direct |
1,065
-13.59%
|
$38,340
$36.54 P/Share
|
|
Jun 18
2021
|
Dawn Svoronos Director |
SELL
Open market or private sale
|
Direct |
1,609
-30.4%
|
$57,924
$36.54 P/Share
|
|
Jun 17
2021
|
Wendy L Yarno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+27.93%
|
-
|
|
Jun 17
2021
|
Scott W Morrison Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+27.93%
|
-
|
|
Jun 17
2021
|
Philip A. Pizzo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+27.93%
|
-
|
|
Jun 17
2021
|
Deval L Patrick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+35.84%
|
-
|
|
Jun 17
2021
|
Willie L. Brown Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+7.18%
|
-
|
|
Jun 17
2021
|
Glenn Pierce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+11.74%
|
-
|
|
Jun 17
2021
|
Mark L Perry Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+8.14%
|
-
|
|
Jun 17
2021
|
Dawn Svoronos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+36.46%
|
-
|
|
May 10
2021
|
Eric Fink Chief Human Resources Officer |
BUY
Open market or private purchase
|
Direct |
500
+8.83%
|
$18,500
$37.96 P/Share
|
|
Apr 01
2021
|
David Lee Johnson Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-4.76%
|
$63,546
$42.62 P/Share
|
|
Apr 01
2021
|
David Lee Johnson Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+12.1%
|
-
|